AGD1/USP10/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer
Abstract Background Most patients with prostate cancer inevitably progress to castration-resistant prostate cancer (CRPC), at which stage chemotherapeutics like docetaxel become the first-line treatment. However, chemotherapy resistance typically develops after an initial period of therapeutic effic...
Saved in:
Main Authors: | Hong Wang, Chunli Cui, Weiyi Li, Hui Wu, Jianjun Sha, Jiahua Pan, Wei Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-025-03272-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
by: Chenlin Liu, et al.
Published: (2025-01-01) -
METTL10 attenuates adriamycin-induced podocyte injury by targeting cell dedifferentiation
by: Jiwen Bao, et al.
Published: (2025-01-01) -
METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
by: Mei Pu, et al.
Published: (2025-01-01) -
USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1
by: Wensun Chen, et al.
Published: (2025-02-01) -
Association between METTL14 gene polymorphisms and risk of ovarian endometriosis
by: Zijun Zhou, et al.
Published: (2025-01-01)